 | • レポートコード：MRC2-11QY12227 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は院内感染症検査のグローバル市場について調査・分析したレポートです。種類別（機器・試薬、消耗品）市場規模、用途別（疾病検査、薬剤耐性検査）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別院内感染症検査の競争状況、市場シェア ・世界の院内感染症検査市場：種類別市場規模 2015年-2020年（機器・試薬、消耗品） ・世界の院内感染症検査市場：種類別市場規模予測 2021年-2026年（機器・試薬、消耗品） ・世界の院内感染症検査市場：用途別市場規模 2015年-2020年（疾病検査、薬剤耐性検査） ・世界の院内感染症検査市場：用途別市場規模予測 2021年-2026年（疾病検査、薬剤耐性検査） ・北米の院内感染症検査市場分析：米国、カナダ ・ヨーロッパの院内感染症検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの院内感染症検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の院内感染症検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの院内感染症検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Life technologies、Diatherix laboratories、Qiagen GmbH、Meridian Biosciences、Nordion、Roche、Cantel Medical Corporation、Cepheid ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections such as cardio vascular infection, gastrointestinal infections & respiratory infections.
One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis. Other aspects supporting industry growth are growing demand of HAI diagnostics from middle and low-income countries such as India and Brazil, development of technologically advanced diagnostic products, rising awareness among healthcare workers, and initiatives taken by governments to counter the prevalence of HAIs. However, decreasing prevalence of nosocomial infections in the developed countries owing to improved healthcare infrastructure and rising awareness are expected to restrict industry growth.
Market Analysis and Insights: Global Hospital Acquired Disease Testing Market
The global Hospital Acquired Disease Testing market size is projected to reach US$ 508.7 million by 2026, from US$ 453.2 million in 2020, at a CAGR of 11.3%% during 2021-2026.
Global Hospital Acquired Disease Testing Scope and Market Size
Hospital Acquired Disease Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Life technologies
Diatherix laboratories
Qiagen GmbH
Meridian Biosciences
Nordion
Roche
Cantel Medical Corporation
Cepheid
Market segment by Type, the product can be split into
Instrument and Reagents
Consumables
Market segment by Application, split into
Disease Testing
Drug-Resistance Testing
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Acquired Disease Testing Revenue
1.4 Market by Type
1.4.1 Global Hospital Acquired Disease Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instrument and Reagents
1.4.3 Consumables
1.5 Market by Application
1.5.1 Global Hospital Acquired Disease Testing Market Share by Application: 2020 VS 2026
1.5.2 Disease Testing
1.5.3 Drug-Resistance Testing
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Disease Testing Market Perspective (2015-2026)
2.2 Global Hospital Acquired Disease Testing Growth Trends by Regions
2.2.1 Hospital Acquired Disease Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Acquired Disease Testing Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Acquired Disease Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Acquired Disease Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Acquired Disease Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Disease Testing Players by Market Size
3.1.1 Global Top Hospital Acquired Disease Testing Players by Revenue (2015-2020)
3.1.2 Global Hospital Acquired Disease Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Acquired Disease Testing Market Concentration Ratio
3.2.1 Global Hospital Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Disease Testing Revenue in 2019
3.3 Hospital Acquired Disease Testing Key Players Head office and Area Served
3.4 Key Players Hospital Acquired Disease Testing Product Solution and Service
3.5 Date of Enter into Hospital Acquired Disease Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Acquired Disease Testing Historic Market Size by Type (2015-2020)
4.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Acquired Disease Testing Market Size by Application (2015-2020)
5.2 Global Hospital Acquired Disease Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Acquired Disease Testing Market Size (2015-2020)
6.2 Hospital Acquired Disease Testing Key Players in North America (2019-2020)
6.3 North America Hospital Acquired Disease Testing Market Size by Type (2015-2020)
6.4 North America Hospital Acquired Disease Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Acquired Disease Testing Market Size (2015-2020)
7.2 Hospital Acquired Disease Testing Key Players in Europe (2019-2020)
7.3 Europe Hospital Acquired Disease Testing Market Size by Type (2015-2020)
7.4 Europe Hospital Acquired Disease Testing Market Size by Application (2015-2020)
8 China
8.1 China Hospital Acquired Disease Testing Market Size (2015-2020)
8.2 Hospital Acquired Disease Testing Key Players in China (2019-2020)
8.3 China Hospital Acquired Disease Testing Market Size by Type (2015-2020)
8.4 China Hospital Acquired Disease Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Acquired Disease Testing Market Size (2015-2020)
9.2 Hospital Acquired Disease Testing Key Players in Japan (2019-2020)
9.3 Japan Hospital Acquired Disease Testing Market Size by Type (2015-2020)
9.4 Japan Hospital Acquired Disease Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Acquired Disease Testing Market Size (2015-2020)
10.2 Hospital Acquired Disease Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Acquired Disease Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Acquired Disease Testing Market Size by Application (2015-2020)
11 India
11.1 India Hospital Acquired Disease Testing Market Size (2015-2020)
11.2 Hospital Acquired Disease Testing Key Players in India (2019-2020)
11.3 India Hospital Acquired Disease Testing Market Size by Type (2015-2020)
11.4 India Hospital Acquired Disease Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Acquired Disease Testing Market Size (2015-2020)
12.2 Hospital Acquired Disease Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Acquired Disease Testing Market Size by Type (2015-2020)
12.4 Central & South America Hospital Acquired Disease Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Life technologies
13.1.1 Life technologies Company Details
13.1.2 Life technologies Business Overview
13.1.3 Life technologies Hospital Acquired Disease Testing Introduction
13.1.4 Life technologies Revenue in Hospital Acquired Disease Testing Business (2015-2020))
13.1.5 Life technologies Recent Development
13.2 Diatherix laboratories
13.2.1 Diatherix laboratories Company Details
13.2.2 Diatherix laboratories Business Overview
13.2.3 Diatherix laboratories Hospital Acquired Disease Testing Introduction
13.2.4 Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.2.5 Diatherix laboratories Recent Development
13.3 Qiagen GmbH
13.3.1 Qiagen GmbH Company Details
13.3.2 Qiagen GmbH Business Overview
13.3.3 Qiagen GmbH Hospital Acquired Disease Testing Introduction
13.3.4 Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.3.5 Qiagen GmbH Recent Development
13.4 Meridian Biosciences
13.4.1 Meridian Biosciences Company Details
13.4.2 Meridian Biosciences Business Overview
13.4.3 Meridian Biosciences Hospital Acquired Disease Testing Introduction
13.4.4 Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.4.5 Meridian Biosciences Recent Development
13.5 Nordion
13.5.1 Nordion Company Details
13.5.2 Nordion Business Overview
13.5.3 Nordion Hospital Acquired Disease Testing Introduction
13.5.4 Nordion Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.5.5 Nordion Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Hospital Acquired Disease Testing Introduction
13.6.4 Roche Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Cantel Medical Corporation
13.7.1 Cantel Medical Corporation Company Details
13.7.2 Cantel Medical Corporation Business Overview
13.7.3 Cantel Medical Corporation Hospital Acquired Disease Testing Introduction
13.7.4 Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.7.5 Cantel Medical Corporation Recent Development
13.8 Cepheid
13.8.1 Cepheid Company Details
13.8.2 Cepheid Business Overview
13.8.3 Cepheid Hospital Acquired Disease Testing Introduction
13.8.4 Cepheid Revenue in Hospital Acquired Disease Testing Business (2015-2020)
13.8.5 Cepheid Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hospital Acquired Disease Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital Acquired Disease Testing Revenue
Table 3. Ranking of Global Top Hospital Acquired Disease Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital Acquired Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Instrument and Reagents
Table 6. Key Players of Consumables
Table 7. Global Hospital Acquired Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hospital Acquired Disease Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hospital Acquired Disease Testing Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hospital Acquired Disease Testing Market Share by Regions (2015-2020)
Table 11. Global Hospital Acquired Disease Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hospital Acquired Disease Testing Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hospital Acquired Disease Testing Market Growth Strategy
Table 17. Main Points Interviewed from Key Hospital Acquired Disease Testing Players
Table 18. Global Hospital Acquired Disease Testing Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hospital Acquired Disease Testing Market Share by Players (2015-2020)
Table 20. Global Top Hospital Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Disease Testing as of 2019)
Table 21. Global Hospital Acquired Disease Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hospital Acquired Disease Testing Product Solution and Service
Table 24. Date of Enter into Hospital Acquired Disease Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hospital Acquired Disease Testing Market Size Share by Type (2015-2020)
Table 28. Global Hospital Acquired Disease Testing Revenue Market Share by Type (2021-2026)
Table 29. Global Hospital Acquired Disease Testing Market Size Share by Application (2015-2020)
Table 30. Global Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hospital Acquired Disease Testing Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 34. North America Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 36. North America Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 38. Europe Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 40. Europe Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 42. Europe Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 44. China Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 46. China Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 47. China Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 48. China Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 49. China Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 50. Japan Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 52. Japan Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 54. Japan Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 58. Southeast Asia Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 60. Southeast Asia Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 62. India Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 64. India Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 65. India Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 66. India Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 67. India Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hospital Acquired Disease Testing Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hospital Acquired Disease Testing Market Share (2019-2020)
Table 70. Central & South America Hospital Acquired Disease Testing Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hospital Acquired Disease Testing Market Share by Type (2015-2020)
Table 72. Central & South America Hospital Acquired Disease Testing Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hospital Acquired Disease Testing Market Share by Application (2015-2020)
Table 74. Life technologies Company Details
Table 75. Life technologies Business Overview
Table 76. Life technologies Product
Table 77. Life technologies Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 78. Life technologies Recent Development
Table 79. Diatherix laboratories Company Details
Table 80. Diatherix laboratories Business Overview
Table 81. Diatherix laboratories Product
Table 82. Diatherix laboratories Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 83. Diatherix laboratories Recent Development
Table 84. Qiagen GmbH Company Details
Table 85. Qiagen GmbH Business Overview
Table 86. Qiagen GmbH Product
Table 87. Qiagen GmbH Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 88. Qiagen GmbH Recent Development
Table 89. Meridian Biosciences Company Details
Table 90. Meridian Biosciences Business Overview
Table 91. Meridian Biosciences Product
Table 92. Meridian Biosciences Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 93. Meridian Biosciences Recent Development
Table 94. Nordion Company Details
Table 95. Nordion Business Overview
Table 96. Nordion Product
Table 97. Nordion Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 98. Nordion Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Cantel Medical Corporation Company Details
Table 105. Cantel Medical Corporation Business Overview
Table 106. Cantel Medical Corporation Product
Table 107. Cantel Medical Corporation Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 108. Cantel Medical Corporation Recent Development
Table 109. Cepheid Business Overview
Table 110. Cepheid Product
Table 111. Cepheid Company Details
Table 112. Cepheid Revenue in Hospital Acquired Disease Testing Business (2015-2020) (Million US$)
Table 113. Cepheid Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Disease Testing Market Share by Type: 2020 VS 2026
Figure 2. Instrument and Reagents Features
Figure 3. Consumables Features
Figure 4. Global Hospital Acquired Disease Testing Market Share by Application: 2020 VS 2026
Figure 5. Disease Testing Case Studies
Figure 6. Drug-Resistance Testing Case Studies
Figure 7. Hospital Acquired Disease Testing Report Years Considered
Figure 8. Global Hospital Acquired Disease Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Hospital Acquired Disease Testing Market Share by Regions: 2020 VS 2026
Figure 10. Global Hospital Acquired Disease Testing Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Hospital Acquired Disease Testing Market Share by Players in 2019
Figure 13. Global Top Hospital Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Disease Testing as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Hospital Acquired Disease Testing Revenue in 2019
Figure 15. North America Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Hospital Acquired Disease Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
腸疾患検査の世界市場（～2026年） Enteric diseases are gastrointestinal infections caused by microbes such as bacteria, viruses, and parasites when they enter the body through the mouth or intestinal systems. The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease …- 感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…
- 感染症検査における分子診断の世界市場（～2026年） Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- 呼吸器疾患検査/診断の世界市場（～2026年） Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters. The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing pop…
- 後天性孤児血液疾患の世界市場（～2026年） Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body?s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …